Maureen Martinez

Maureen Martinez

Auto-generated profile, based on publicly available information

Maureen Martinez

The Centers for Disease Control and Prevention, Atlanta, GA 30329-4027, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2020 in MMWR. Morbidity and Mortality Weekly Report
Verified
Journal Article
Closed access
MMMaureen Martinez
Maureen Martinez
IAIrfan Elahi Akbar
Irfan Elahi Akbar
MWMufti Zubair Wadood
Mufti Zubair Wadood
HSHemant Shukla
Hemant Shukla
JJJaume Jorba
Jaume Jorba
DEDerek Ehrhardt
Derek Ehrhardt
This report describes the increase of wild poliovirus circulation in Afghanistan.

23 August 2019 in MMWR. Morbidity and Mortality Weekly Report
Verified
Journal Article
Closed access
MMMaureen Martinez
Maureen Martinez
HSHemant Shukla
Hemant Shukla
JNJoanna Nikulin
Joanna Nikulin
CMChukwuma Mbaeyi
Chukwuma Mbaeyi
JJJaume Jorba
Jaume Jorba
DEDerek Ehrhardt
Derek Ehrhardt
This report describes polio eradication activities and progress in Afghanistan during January 2018–May 2019.

3 August 2018 in MMWR. Morbidity and Mortality Weekly Report
Verified
Journal Article
Closed access
MMMaureen Martinez
Maureen Martinez
HSHemant Shukla
Hemant Shukla
MAMeiland Ahmadi
Meiland Ahmadi
JIJoanna Inulin
Joanna Inulin
MWMufti Sabari Widodo
Mufti Sabari Widodo
DGDerek Gerhardt
Derek Gerhardt
Since 2016, the annual number of reported wild poliovirus cases in Afghanistan has remained steady.

18 August 2017 in MMWR. Morbidity and Mortality Weekly Report
Verified
Journal Article
Open access
MMMaureen Martinez
Maureen Martinez
HSHemant Shukla
Hemant Shukla
JNJoanna Nikulin
Joanna Nikulin
MWMufti Zubair Wadood
Mufti Zubair Wadood
SHStephen Hadler
Stephen Hadler
DEDerek Ehrhardt
Derek Ehrhardt
Wild poliovirus type 1 cases in Afghanistan continue to decline.

16 October 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
Sajid Bashir SoofiSajid Bashir Soofi
Sajid Bashir Soofi
MMMaureen Martinez
Maureen Martinez
NFNoha H. Farag
Noha H. Farag
WHWilliam S. Hendley
William S. Hendley
DEDerek Ehrhardt
Derek Ehrhardt
AKAhmed M. Kassem
Ahmed M. Kassem
Afghanistan is one of two countries where wild poliovirus (WPV) type 1 remains endemic. We conducted a facility-based cross-sectional survey of antipoliovirus antibodies in children in 14 provinces of Afghanistan. The provinces were selected based on programmatic priorities for polio eradication. Children aged 6–11 and 36–48 months attending outpatient clinics were enrolled in the study. We collected venous blood, isolated serum, and conducted neutralization assays to detect poliovirus neutralizing antibodies. A total of 2086 children from the 14 provinces were enrolled. Among the enrolled children, 44.3% were girls; the median age in the 6–11-month group was 9.4 months, and in the 36–48-month group, it was 41.8 months. The most common spoken language was Pashtu (70.8%). Eighty-two percent of children were fully immunized against all the diseases in the vaccination schedule of Afghanistan. In the children aged 6–11 months, seroprevalence to poliovirus type 1 (PV1) was 96.5% and seroprevalence to poliovirus type 3 (PV3) was 93%; in children aged 36–48 months, seroprevalence to PV1 was 99.5% and to PV3 was 98%. Antipoliovirus antibody prevalence for poliovirus type 2 (PV2) was 70.5% in the younger group compared with 90.9% in the older children. Children from Herat and Laghman provinces had almost 100% seroprevalence to PV1, and other provinces also had high prevalence, ranging from 92.0% to 99.0%. A similar finding was seen for antibodies against PV3, ranging from 88% to 100% by province. On the contrary, antibodies to PV2 were low, ranging from 53% for children in the Khost province to around 89% in Kunduz. There was a cluster of 18 seronegative children in the Nuristan province. Overall, the polio eradication program of Afghanistan has been successful in achieving high seroprevalence of poliovirus neutralizing antibodies in the parts of the country included in this study.

29 August 2022 in Geospatial Health
Verified
Journal Article
Open access
PDF file
AMAmalia Mendes
Amalia Mendes
AWAri Whiteman
Ari Whiteman
BNBenjamin Nygren
Benjamin Nygren
BKBrian Kaplan
Brian Kaplan
Imtiaz HussainImtiaz Hussain
Imtiaz Hussain
NFNoha H. Farag
Noha H. Farag
Afghanistan continues to experience challenges affecting polio eradication. Mass polio vaccination campaigns, which aim to protect children under the age of 5, are a key eradication strategy. To date, the polio program in Afghanistan has only employed facility-based seroprevalence surveys, which can be subject to sampling bias. We describe the feasibility in implementing a cross-sectional household poliovirus seroprevalence survey based on geographical information systems (GIS) in three districts. Digital maps with randomly selected predetermined starting points were provided to teams, with a total target of 1,632 households. Teams were instructed to navigate to predetermined starting points and enrol the closest household within 60 m. To assess effectiveness of these methods, we calculated percentages for total households enrolled with valid geocoordinates collected within the designated boundary, and whether the Euclidean distance of households were within 60 m of a predetermined starting point. A normalized difference vegetation index (NDVI) image ratio was conducted to further investigate variability in team performances. The study enrolled a total of 78% of the target sample with 52% of all households within 60 m of a pre-selected point and 79% within the designated cluster boundary. Success varied considerably between the four target areas ranging from 42% enrolment of the target sample in one place to 90% enrolment of the target sample in another. Interviews with the field teams revealed that differences in security status and amount of non-residential land cover were key barriers to higher enrolment rates. Our findings indicate household poliovirus seroprevalence surveys using GIS-based sampling can be effectively implemented in polio endemic countries to capture representative samples. We also proposed ways to achieve higher success rates if these methods are to be used in the future, particularly in areas with concerns of insecurity or spatially dispersed residential units.
1